Consumer Health sales rose 3.5%, with growth in all but one category. Bayer said the Apollo transaction is expected to close in the second half and reduce net financial debt. It now expects year-end net financial debt of €29 billion to €30 billion, compared with its previous target of €32 billion to €33 billion. In Crop Science, Bayer announced a licensing agreement for broad commercialization of hybrid wheat. About Bayer Aktiengesellschaft (ETR:BAYN)Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide.